A Study Looking At the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients with Sepsis (Limiting AKI Progression in Sepsis)

NATerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

February 14, 2022

Study Completion Date

February 14, 2022

Conditions
SepsisAcute Kidney InjurySeptic Shock
Interventions
DEVICE

Subject management guided by NephroCheck® test

NephroCheck® is a device using biomarkers to identify subjects at risk of sepsis-associated acute kidney injury

OTHER

Standard of Care

Standard of Care patient management

Trial Locations (12)

1070

Hôpital Erasme, Soins Intensifs, Route de Lennik 808, Brussels

8000

AZ Sint-Jan Brugge-Oostende, Intensieve Zorgen, Ruddershove 10, Bruges

10065

Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York

21079

CHRU Dijon Complexe Du Bocage, Department Infectiologie, 14 rue Gaffarel, Dijon

48149

Universitatsklinikum Munster, Albert-Schweitzer-Campus 1, Münster

49100

CHU Angers, 4 Rue Larrey, Angers

62408

Centre Hospitalier de Béthune, Service de Réanimation et Surveillance continue, 27 rue Delbecque, Béthune

69120

University Clinic Heidelberg, Klinik für Anaesthesiologie, Im Neuenheimer Feld 110, Heidelberg

71130

LSU Health Sciences Center, 1541 Kings Highway, Shreveport

75679

Hopital Cochin, 27 Rue Du Faubourg Saint Jacques, Paris

02115

Brigham and Womens Hospital, 75 Francis Street, Boston

04103

Universitatsklinikum Leipzig, Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Liebigstraße 20, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioMérieux

INDUSTRY